申请人:Warner-Lambert Company
公开号:US05393923A1
公开(公告)日:1995-02-28
The present invention is a novel compound which is a 3,5-di-t-butyl-4-hydroxyphenylmethylhydroxylamine or derivative thereof and a pharmaceutically acceptable acid addition or base salt thereof, pharmaceutical composition and methods of use therefor. The invention compounds are now found to have activity as inhibitors of one or both of cyclooxygenase and 5-lipoxygenase providing treatment of conditions advantageously affected by such inhibition including inflammation, arthritis, pain, fever, and the like.
本发明是一种新型化合物,其为3,5-二叔丁基-4-羟基苯甲基羟胺或其衍生物及其药学上可接受的酸加合物或碱盐,以及使用该化合物的药物组合物和方法。发明化合物现已发现具有抑制环氧合酶和5-脂氧合酶中的一种或两种的活性,可治疗有利受到此类抑制影响的炎症、关节炎、疼痛、发热等病症。